BDBM658030 1-(4-fluoro-2- isopropylphenyl)- 3-(2-methyl-6- oxo-1,6-dihydro- pyridin-3-yl)-6- (trifluoromethyl)- 2,3-dihydropyr- ido[3,4-d]pyrim- idin-4(1H)-one::US20240083896, Example 5

SMILES Cc1[nH]c(=O)ccc1N1CN(c2ccc(F)cc2C(C)C)c2cnc(C(F)(F)F)cc2C1=O

InChI Key InChIKey=ZOFYFABDAAWNLG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 658030   

TargetSodium channel protein type 5 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 658030BDBM658030(US20240083896, Example 5 | 1-(4-fluoro-2- isopropy...)
Affinity DataIC50: 63.1nMAssay Description:Pharmacological assessment of the compounds of the invention was performed using HEK293-Nav1.8 in combination with an assay developed on the QPatch 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent